Hormone Replacement Therapy (HRT) Market Size, Share & Industry Analysis, By Therapy Type (Estrogen and Combinations Replacement Therapy, Growth Hormone Replacement Therapy, Thyroid Hormone Replacement Therapy), By Indication (Menopause, Hypothyroidism, Male Hypogonadism, and Growth Hormone Deficiency), By Route of Administration (Oral, Transdermal, and Parenteral), By Distribution Channel (Hospital Pharmacies), and Regional Forecast, 2019-2026 (Includes COVID-19 Business Impact)

                                          
We have updated Hormone Replacement Therapy (HRT) Market with respect to COVID-19 Business Impact.
Inquire before buying


This report focuses on the Hormone Replacement Therapy (HRT) market and value at the global level, regional level, and company level. From a global perspective, this report represents the overall Hormone Replacement Therapy (HRT) market size by analyzing historical data and future prospects. Regionally, this report focuses on several key regions: North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America.


Global Hormone Replacement Therapy (HRT) Market: Segment Analysis


The research report includes specific segments by region (country), by Company, by Type, and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2019 to 2029. An in-depth analysis of the segments assists in identifying the different factors that will aid market growth.


Global Hormone Replacement Therapy (HRT) Market: Regional Analysis


The research report includes a detailed study of regions of North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America. The report has been curated after observing and studying various factors that determine regional growth such as the economic, environmental, social, technological, and political status of the particular region. Researchers have studied the data of revenue, sales, and manufacturers of each mentioned region. This section analyses region-wise revenue and volume for the forecast period of 2019 to 2029.


Global Hormone Replacement Therapy (HRT) Market: Competitive Landscape


This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2019 to 2029.
List of Companies Profiled

Diverse product portfolio of Novo Nordisk A/S and Pfizer Inc. to propel the company share
The key players dominating the hormone replacement therapy market are Novo Nordisk A/S and Pfizer Inc. due to its diverse product portfolio across the globe. In terms of revenue, Novo Nordisk holds the dominance owing to its blockbuster product norditropin. The significant upscale of the product across the globe is anticipated to propel the growth of the market during the forecast period. Pfizer Inc. is considered as the prominent market player owing to its focus on the development of the hormone replacement therapy along with its blockbuster product like genotropin supporting in terms of revenue.

However, some of the regional and domestic key players such as Mithra Pharmaceuticals, and others have entered the women"s health market supporting hormone replacement therapy. Therefore, the market is expected to experience tough competition during the forecast period.

LIST OF KEY PLAYERS PROFILED:

  
hormone replacement therapy (HRT)
  
Pfizer Inc.
  
AbbVie Inc.
  
Merck KGaA
  
Endo Pharmaceuticals Solutions Inc.
  
Allergan
  
Eli Lilly and Company
  
Mithra Pharmaceuticals
  
Amgen
  
Others

KEY INDUSTRY DEVELOPMENTS:

January 2020 -CurieMD, telehealth platform launched menopause hormone replacement therapy management through telehealth service which offers women remote consultation, mail-order prescription, and consumer video consultation with midlife health practitioners for the consultation.

October 2018 -TherapeuticsMD, Inc., the company mainly focuses on womens health, announced FDA approval of bijuva consisting of estradiol and progesterone combination capsules for the treatment of vasomotor symptoms during moderate to severe menopause disorders.

REPORT COVERAGE

The hormone replacement therapy market report provides a detailed analysis of the market and focuses on key aspects such as leading companies, therapy types, and leading indications of the therapy. Besides this, the report provides key insights into the market trends and highlights major industry developments such as pipeline analysis, mergers, acquisitions, and collaborations.  In addition to this, the report also focuses on the major driving factors and restraints that are influencing the market growth over the course of the period.

Report Scope & Segmentation

 Segmentation

By Therapy Type

  
Estrogen and combinations replacement
  
Thyroid replacement
  
Growth replacement
  
Testosterone

By Indication

  
Menopause
  
Hypothyroidism
  
Male hypogonadism
  
Growth hormone deficiency

By Route of Administration

  
Oral
  
Transdermal
  
Parenteral

By Distribution Channel

  
Hospitals Pharmacies
  
Retail Pharmacies & Stores
  
Online Pharmacies

By Geography

  
North America (U.S. and Canada)
  
Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
  
Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia- Pacific)
  
Latin America (Brazil, Mexico, and Rest of Latin America)
  
Middle East & Africa (South Africa, GCC, and Rest of Middle East & Africa)